eResearchTechnology, Inc.
eResearchTechnology, Inc., commonly known as ERT, is a leading provider of technology and services for the pharmaceutical and biotechnology industries. Headquartered in the United States, ERT operates across major regions, including Europe and Asia, delivering innovative solutions that enhance clinical trial processes. Founded in 1977, the company has achieved significant milestones, including the integration of advanced data collection technologies. ERT's core offerings encompass cardiac safety, respiratory, and eSource solutions, distinguished by their commitment to accuracy and reliability. The company is recognised for its robust market position, having supported thousands of clinical trials globally. With a focus on improving patient outcomes and streamlining trial efficiency, ERT continues to set industry standards in clinical research technology.
DitchCarbon Score
How does eResearchTechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
eResearchTechnology, Inc.'s score of 43 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
eResearchTechnology, Inc.'s reported carbon emissions
eResearchTechnology, Inc., headquartered in the US, has not publicly disclosed any specific carbon emissions data for the most recent year. However, the company has made significant climate commitments aimed at reducing its greenhouse gas emissions. eResearchTechnology, Inc. has set an ambitious overall net-zero target, committing to achieve net-zero greenhouse gas emissions across its entire value chain by 2045. In the near term, the company aims to reduce its absolute Scope 1 and 2 emissions by approximately 63.6% by 2030, using 2021 as the baseline year. Additionally, it plans to cut its absolute Scope 3 emissions by about 25% within the same timeframe. For the long term, eResearchTechnology, Inc. has committed to a substantial reduction of 90% in absolute emissions across all scopes (1, 2, and 3) by 2045, again referencing the 2021 baseline. These targets align with the science-based targets initiative (SBTi) and are consistent with the reductions necessary to limit global warming to 1.5°C. Through these commitments, eResearchTechnology, Inc. demonstrates its dedication to addressing climate change and reducing its environmental impact in the pharmaceuticals, biotechnology, and life sciences sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
eResearchTechnology, Inc. is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
